EUVIMEDEUVIMED entdecken
Crossref

The Mechanism of Immune Intervention by Iguratimod in Oral Lichen Planus Patients: An In Vitro Experimental Study

Mengna Zhang, Juehua Cheng, Jia Liu, Yanlin Geng, Yuan Fan iD, Liqun Yang iD, Yuchi Zhu iD

Journal of Oral Pathology & Medicine · 2025

DOI: 10.1111/jop.13591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Oral Pathology & Medicine, 2025. Verfasst von Mengna Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Mucosal Diseases, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Lichen Planus, Oral, Chromones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Provincial Medical Innovation Center, Jiangsu Provincial Key Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Oral lichen planus (OLP) is a T cell‐mediated immune disease. Iguratimod (IGU) is a novel immunomodulatory agent for rheumatoid arthritis. No studies have been reported on the mechanism of IGU in the treatment of OLP, which deserves investigation.

Methods

Samples were collected from two batches of non‐erosive OLP, erosive OLP (EOLP) patients and healthy control subjects. In the first batch, the effects of IGU or the same volume of dimethyl sulfoxide (DMSO) on proliferation, apoptosis and migration of peripheral blood T lymphocytes (PBL T) were examined by CCK‐8, flow cytometry and transwell assay respectively. The levels of IL‐6, IL‐17, TNF‐α, TGF‐β and IL‐10 were measured by enzyme‐linked immunosorbent assay. In the second batch, the percentages of Th17 and Treg cells were determined by flow cytometry in peripheral blood mononuclear cells after IGU or DMSO stimulation.

Results

Compared with the control, IGU promoted apoptosis and inhibited migration, but had no significant effect on the proliferation of PBL T in OLP. IL‐6, IL‐17 and TNF‐α were decreased in OLP. TGF‐β and IL‐10 showed an upward trend in the IGU‐treated EOLP. IGU decreased Th17 in OLP and reduced Th17/Treg ratio in EOLP. The percentage of Treg cells showed an upregulated trend but the difference was not statistically significant.

Conclusion

IGU may intervene in the immune response of OLP by affecting functions of PBL T, improving the balance of Th17/Treg and regulating related cytokines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lichen Planus, OralChromonesHumansApoptosisCell ProliferationFemaleMaleAdultCell MovementMiddle AgedCytokinesT-Lymphocytes, RegulatoryTh17 CellsInterleukin-17Case-Control StudiesDimethyl SulfoxideSulfonamides

Stichwörter der Autor:innen

IguratimodTh17/Tregoral lichen planusperipheral blood T lymphocytes

Substanzen

iguratimodChromonesCytokinesInterleukin-17Dimethyl SulfoxideSulfonamides

Autor:innen und Institutionen

  • Department of Oral Mucosal Diseases, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • State Key Laboratory Cultivation Base of Research, Prevention and Treatment for Oral Diseases, Nanjing, Jiangsu, China.
  • Jiangsu Province Engineering Research Center of Stomatological Translational Medicine, Nanjing, Jiangsu, China.
  • The Affiliated Stomatological Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
  • Jiangxi Provincial Key Laboratory of Oral Diseases, Nanchang, Jiangxi, China.
  • Jiangxi Provincial Clinical Research Center for Oral Diseases, Nanchang, Jiangxi, China.

ORCID-Profile: Yuan Fan, Liqun Yang, Yuchi Zhu

Förderung

  • National Natural Science Foundation of China
  • Jiangsu Provincial Medical Innovation Center
  • Jiangsu Provincial Key Research and Development Program
  • Jiangsu Province Capability Improvement Project through Science, Technology and Education-Jiangsu Provincial Research Hospital Cultivation Unit

Zitieren

APA

Zhang, M., Cheng, J., Liu, J., Geng, Y., Fan, Y., Yang, L., & Zhu, Y. (2025). The Mechanism of Immune Intervention by Iguratimod in Oral Lichen Planus Patients: An In Vitro Experimental Study. Journal of Oral Pathology & Medicine. https://doi.org/10.1111/jop.13591

Vancouver

Zhang M, Cheng J, Liu J, Geng Y, Fan Y, Yang L, et al. The Mechanism of Immune Intervention by Iguratimod in Oral Lichen Planus Patients: An In Vitro Experimental Study. Journal of Oral Pathology & Medicine. 2025. doi:10.1111/jop.13591

BibTeX
@article{Zhang2025,
  author = {Zhang, Mengna and Cheng, Juehua and Liu, Jia and Geng, Yanlin and Fan, Yuan and Yang, Liqun and Zhu, Yuchi},
  title = {The Mechanism of Immune Intervention by Iguratimod in Oral Lichen Planus Patients: An In Vitro Experimental Study},
  journal = {Journal of Oral Pathology & Medicine},
  year = {2025},
  doi = {10.1111/jop.13591}
}
Kostenlos starten →